Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Total Current Liabilities: 2023-2024

Historic Total Current Liabilities for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $21.4 million.

  • CG Oncology's Total Current Liabilities rose 95.32% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year increase of 95.32%. This contributed to the annual value of $21.4 million for FY2024, which is 49.91% up from last year.
  • Per CG Oncology's latest filing, its Total Current Liabilities stood at $21.4 million for FY2024, which was up 49.91% from $14.3 million recorded in FY2023.
  • CG Oncology's Total Current Liabilities' 5-year high stood at $21.4 million during FY2024, with a 5-year trough of $14.3 million in FY2023.
  • Its 2-year average for Total Current Liabilities is $17.8 million, with a median of $17.8 million in 2023.
  • Data for CG Oncology's Total Current Liabilities shows a peak YoY spiked of 49.91% (in 2024) over the last 5 years.
  • CG Oncology's Total Current Liabilities (Yearly) stood at $14.3 million in 2023, then soared by 49.91% to $21.4 million in 2024.